Meridian Investment Counsel’s Medtronic MDT Stock Holding History

Meridian Investment Counsel’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Sell	26,711 -1,414	-5%	-$114K	0.45%	71
2026 Q1	$2.44M	Hold	28,125	–	–	0.58%	55
2025 Q4	$2.7M	Sell	28,125 -143	-0.5%	-$13.9K	0.65%	46
2025 Q3	$2.69M	Buy	28,268 +110	+0.4%	+$10.1K	0.66%	41
2025 Q2	$2.45M	Buy	28,158 +772	+3%	+$65.5K	0.67%	43
2025 Q1	$2.46M	Buy	27,386 +2,452	+10%	+$219K	0.72%	41
2024 Q4	$1.99M	Buy	24,934 +12,297	+97%	+$1.06M	0.59%	46
2024 Q3	$1.14M	Buy	12,637 +7,948	+170%	+$669K	0.34%	83
2024 Q2	$369K	Hold	4,689	–	–	0.12%	159
2024 Q1	$409K	Sell	4,689 -20	-0.4%	-$1.71K	0.14%	150
2023 Q4	$388K	Hold	4,709	–	–	0.13%	151
2023 Q3	$369K	Buy	4,709 +19	+0.4%	+$1.59K	0.14%	148
2023 Q2	$413K	Sell	4,690 -167	-3%	-$14.4K	0.15%	146
2023 Q1	$392K	Hold	4,857	–	–	0.15%	143
2022 Q4	$377K	Buy	4,857 +329	+7%	+$26.7K	0.15%	144
2022 Q3	$366K	Buy	4,528 +25	+0.6%	+$2.25K	0.16%	135
2022 Q2	$404K	Hold	4,503	–	–	0.17%	129
2022 Q1	$500K	Hold	4,503	–	–	0.17%	128
2021 Q4	$466K	Hold	4,503	–	–	0.15%	136
2021 Q3	$564K	Sell	4,503 -71	-2%	-$9.19K	0.2%	108
2021 Q2	$568K	Sell	4,574 -71	-2%	-$8.91K	0.2%	111
2021 Q1	$549K	Hold	4,645	–	–	0.21%	109
2020 Q4	$544K	Sell	4,645 -478	-9%	-$52.6K	0.23%	103
2020 Q3	$532K	Hold	5,123	–	–	0.26%	93
2020 Q2	$470K	Hold	5,123	–	–	0.24%	98
2020 Q1	$462K	Hold	5,123	–	–	0.3%	87
2019 Q4	$581K	Hold	5,123	–	–	0.29%	89
2019 Q3	$556K	Hold	5,123	–	–	0.3%	89
2019 Q2	$499K	Buy	5,123 +20	+0.4%	+$1.83K	0.28%	92
2019 Q1	$465K	Hold	5,103	–	–	0.27%	96
2018 Q4	$464K	Hold	5,103	–	–	0.3%	88
2018 Q3	$502K	Hold	5,103	–	–	0.27%	93
2018 Q2	$437K	Hold	5,103	–	–	0.25%	106
2018 Q1	$409K	Sell	5,103 -453	-8%	-$37.4K	0.23%	110
2017 Q4	$449K	Sell	5,556 -100	-2%	-$8.01K	0.24%	102
2017 Q3	$440K	Buy	5,656 +135	+2%	+$11.2K	0.25%	102
2017 Q2	$490K	Hold	5,521	–	–	0.29%	95
2017 Q1	$445K	Hold	5,521	–	–	0.27%	98
2016 Q4	$393K	Sell	5,521 -310	-5%	-$24.4K	0.26%	102
2016 Q3	$504K	Hold	5,831	–	–	0.34%	89
2016 Q2	$506K	Sell	5,831 -43	-0.7%	-$3.48K	0.34%	86
2016 Q1	$441K	Hold	5,874	–	–	0.31%	96
2015 Q4	$452K	Hold	5,874	–	–	0.33%	90
2015 Q3	$393K	Hold	5,874	–	–	0.32%	92
2015 Q2	$435K	Hold	5,874	–	–	0.31%	94
2015 Q1	$458K	Buy	+5,874	New	+$445K	0.32%	93

Other funds holding MDT

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

GAM

Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Meridian Investment Counsel's MDT Position: Q2 2026 in Review

Meridian Investment Counsel reduced its Medtronic (MDT) stake by 5% in Q2 2026, selling an estimated $114K and leaving 26,711 shares worth $2.09M. The position accounts for 0.45% of the portfolio, ranked #71.

Meridian Investment Counsel first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.7M in Q4 2025. 825 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Meridian Investment Counsel held 26,711 shares of Medtronic worth $2.09M as of Q2 2026.
Meridian Investment Counsel sold 1,414 Medtronic shares in Q2 2026, an estimated $114K.
Medtronic made up 0.45% of Meridian Investment Counsel's portfolio in Q2 2026, its #71 holding.
Meridian Investment Counsel first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
Meridian Investment Counsel's Medtronic position peaked at $2.7M in Q4 2025.
825 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.